Loading...
Market
Most impactful outcome on modern cancer research by end of 2024
3
Resolution / Starting Odds
New surgical techniques • 25%
Improved understanding of cancer history • 25%
No significant impact • 25%
Other • 25%
Surveys or interviews with recognized oncologists
Story
Ancient Egyptians Attempted to Surgically Treat Brain Cancer, 4,000-Year-Old Skull Shows
May 29, 2024, 05:46 AM
A recent study has revealed that ancient Egyptians attempted to surgically treat brain cancer, as evidenced by a 4,000-year-old skull. This skull, which shows signs of brain cancer, offers extraordinary clues about early medical practices. Tiny etchings on the skull suggest that the ancient Egyptians may have been the first people to try to treat cancer. The findings, published by scientists, indicate that these early attempts at understanding and treating cancer date back more than 4,000 years.
View original story
Similar markets
Treatment Options • 25%
Clinical Trials • 25%
Patient Support • 25%
Research News • 25%
Significant tumor reduction in >75% of patients • 33%
Moderate tumor reduction in 50-75% of patients • 33%
Less than 50% of patients show tumor reduction • 34%
Significant decrease • 25%
Moderate decrease • 25%
No impact • 25%
Increase in traditional exams • 25%
Prostate Cancer • 25%
Breast Cancer • 25%
Lung Cancer • 25%
Pancreatic Cancer • 25%
No policy changes • 33%
Policy changes enacted • 33%
Funding cut or reallocated • 33%
Significant increase in screenings • 33%
Moderate increase in screenings • 33%
No significant change in screenings • 34%
Significant increase • 33%
No change • 33%
Decrease • 33%
Less than 10% • 25%
10% to 25% • 25%
26% to 50% • 25%
More than 50% • 25%
Virology • 25%
Genetic engineering • 25%
Immunology • 25%
Other • 25%
Increase in violations • 33%
Decrease in violations • 33%
No significant change • 34%
Supports Existing Theories • 33%
Challenges Existing Theories • 33%
No Significant Impact • 34%
Drug discovery • 25%
Genetic research • 25%
Cancer research • 25%
Antibody development • 25%